EFFECTIVENESS OF ERLOTINIB IN ADVANCED NON-SMALL-CELL LUNG CANCER AFTER FAILURE OF GEFITINIB

被引：0
|
作者：
Saito, Haruhiro [1 ]
Murakami, Shuji [1 ]
Honda, Takeshi [1 ]
Kondo, Tetsuro [1 ]
Oshita, Fumihiro [1 ]
Noda, Kazumasa [1 ]
Yamada, Kouzo [1 ]
机构：
[1] Kanagawa Canc Ctr, Dept Thorac Oncol, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [1] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zheng-Tao Zhou
    Xin-Hua Xu
    Qing Wei
    Ming-qian Lu
    Jie Wang
    Cai-Hong Wen
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 64 : 1123 - 1127
  • [2] Erlotinib in advanced non-small-cell lung cancer after gefitinib failure
    Zhou, Zheng-Tao
    Xu, Xin-Hua
    Wei, Qing
    Lu, Ming-qian
    Wang, Jie
    Wen, Cai-Hong
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (06) : 1123 - 1127
  • [3] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Grossi, Francesco
    Rijavec, Erika
    Dal Bello, Maria Giovanna
    Defferrari, Carlotta
    Brianti, Annalisa
    Barletta, Giulia
    Genova, Carlo
    Murolo, Carmelina
    Cosso, Maurizio
    Fontanini, Gabriella
    Boldrini, Laura
    Truini, Mauro
    Pronzato, Paolo
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1407 - 1412
  • [4] The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib
    Francesco Grossi
    Erika Rijavec
    Maria Giovanna Dal Bello
    Carlotta Defferrari
    Annalisa Brianti
    Giulia Barletta
    Carlo Genova
    Carmelina Murolo
    Maurizio Cosso
    Gabriella Fontanini
    Laura Boldrini
    Mauro Truini
    Paolo Pronzato
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 1407 - 1412
  • [5] Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib
    Cho, Byoung Chul
    Im, Chong-Kun
    Park, Moo-Suk
    Kim, Se Kyu
    Chang, Joon
    Park, Jong Pil
    Choi, Hye Jin
    Kim, Yu Jin
    Shin, Sang-Joon
    Sohn, Joo Hyuk
    Kim, Hoguen
    Kim, Joo Hang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2528 - 2533
  • [6] Is erlotinib really active after failure of gefitinib in advanced non-small-cell lung cancer patients?
    Vasile, E.
    Tibaldi, C.
    Falcone, A.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (04) : 790 - 791
  • [7] Erlotinib for relapsed or refractory Non-Small-Cell Lung Cancer after failure of gefitinib
    Nishihira, Ryuichi
    Ogura, Takashi
    Tajiri, Michihiko
    Kato, Terufumi
    Sekine, Akimasa
    Shinohara, Takeshi
    Baba, Tomohisa
    Takahashi, Hiroshi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S703 - S703
  • [8] Erlotinib or Gefitinib for Non-Small-Cell Lung Cancer
    Yusuf, Syed W.
    Kim, Peter
    Durand, Jean-Bernard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (24): : 2367 - 2367
  • [9] Comparison of Gefitinib and Erlotinib for Patients with Advanced Non-Small-Cell Lung Cancer
    Lee, Jin Hwa
    Lee, Kyoung Eun
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (04) : 280 - 287
  • [10] Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
    Passaro, Antonio
    Alesini, Daniele
    Pochesci, Alessia
    Cortesi, Enrico
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (05) : 646 - 650
12345